3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
1
Metabolic Syndrome
1
Interventions
Metformin
2
semaglutide
1
maltodextrin
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Vascular Stiffness
1
Topiramate
1
Tirzepatide
1
Qsymia
1
Pulse Wave Analysis
1
Phentermine
1
Observation
1
Naltrexone
1
Liraglutide
1
Inositol
1
Glucagon-Like Peptide-1 Receptor
1
Exercise
1
Electrocardiography
1
Echocardiography
1
Diethylpropion
1
Diet, Reducing
1
Diet Therapy
1
Contraceptives, Oral
1
Caloric Restriction
1
Bupropion
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Syndrome
×
Contraceptives, Oral
×
1 year
×
Clear all
NCT06852365
2026-06-01
COR-PCOS
University of Pennsylvania
Phase 2
Recruiting
100 enrolled